Close
ACHEMA MIDDLE EAST 2026

Is Pancorona Virus Vaccine Possible? Dr. Weissman Says So

On the opening day of the 19th edition of BioAsia, a special fireside chat between Dr. Sangita Reddy, MD, of Apollo Hospitals and Dr....

WHO Puts In Place Another Training Hub For Biomanufacturing

WHO along with its academy and the Republic of Korea, have announced the inception of a global bio manufacturing training hub that will be...

MNC Pharmaceutical Giants Restructure Their India Presence

Earlier in February this year, Novartis, which happens to be a Swiss drug major, sold its three rooted brands to Dr Reddy’s Laboratories in...

To Grow Biologics Recipharm Buys Arranta And Vibalogics

Recipharm, the Swedish CDMO, which happens to be Moderna’s COVID-19 vaccine production partner, has undergone not one but two acquisitions in the week ending...

Xanadu Executes Yale Tech In Developing Intranasal Booster

Xanadu Bio, in association with Yale University, has come up with a nanoparticle delivery platform that will help to position itself to give its...

Moderna And Spanish CDMO Rovi Extend Contract To Ten Years

A contract extension has been put in place between Moderna, Inc. and Spain’s Rovi, which shall cover the production of formers vaccine doses, including...

To Treat COVID WHO Approves Monoclonal Antibody Tocilizumab

In order to increase access to treatments that are recommended to fight COVID-19, the WHO has added a monoclonal antibody treatment called Tocilizumab to...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...